Diabetes Type 2 Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes
Conditions: Diabetes Type 2; Hypertriglyceridemia; Diabetes Mellitus Interventions: Dietary Supplement: EPAVasc; Dietary Supplement: Corn Oil Sponsors: University of Ioannina; LIBYTEC Pharmaceutical S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials

The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes
Conditions: Insulin Pump ，Continuous Glucose Monitoring Technology Interventions: Drug: Insulin Glargine; Drug: Metformin; Drug: Dapagliflozin; Drug: Insulin aspart Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials

Development of Minimally Invasive Methodology for Diabetyping to Personalise Treatment to Realise Remission and Reversal of Type 2 Diabetes
Conditions: Type 2 Diabetes Sponsors: TNO Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials

Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients
Conditions: Diabetes Mellitus Type 2 Interventions: Drug: Metformin Sponsors: Islamabad Medical and Dental College Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials